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Abstract
Purpose The purpose of the study was to report a case of live
birth following donor oocyte in vitro fertilization/
intracytoplasmic sperm injection (IVF/ICSI) in which the oo-
cyte donor herself was conceived via IVF. To our knowledge,
such a case has not been previously reported.
Methods Retrospective chart review; this case is reported after
chart review of a successful outcome.
Results A 42 year-old woman, with diminished ovarian reserve,
and her husband desired to conceive. She underwent a fresh IVF/
ICSI cycle with her own oocytes, which unfortunately was not
fruitful in terms of pregnancy or cryopreserved embryos. The
couple was counseled regarding the option of donor oocytes,
and they elected to proceed with a fresh cycle of donor oocyte
IVF/ICSI. The couple selected an anonymous oocyte donor from
a donor agency who was a first-time oocyte donor and, interest-
ingly, was conceived via IVF herself. The fresh donor oocyte/
IVF/ICSI cycle did not result in pregnancy; however, two super-
numerary blastocysts were cryopreserved for future cycles. The
recipient’s subsequent frozen-thawed embryo transfer (FET) re-
sulted in a singleton gestation and live birth.
Conclusions An oocyte donor who was conceived via IVF had
good ovarian response to stimulation, a good number of oocytes
retrieved, and the formation and cryopreservation of blastocysts
which, in a subsequent FETcycle, resulted in pregnancy and live
birth for a recipient couple. To our knowledge, this is the first
case reported of live birth with the use of donor oocytes from an
oocyte donor who herself was conceived via IVF.
Keywords Donor oocytes . Oocyte donor . IVF . IVF/ICSI
Introduction
During the initial years of human clinical in vitro fertilization
(IVF) [1], it had been assumed that, in the absence of a signif-
icant genetic and/or metabolic condition that may impact re-
productive capacity, female children born as a result of IVF
would have good fertility potential when they were to reach
reproductive age. Louise Brown, the first person to be born
after having been conceived via IVF, gave birth to a child of
her own in 2008 and again in 2013. In addition, Elizabeth Carr
Comeau, the first person to be born in the US after IVF, con-
ceived spontaneously and delivered her first child in 2010.
Many other women who were conceived via IVF have deliv-
ered children of their own as well. The ovarian reserve of
oocyte donors is a key component of their suitability for oo-
cyte donation, and anti-müllerian hormone (AMH) has been a
strong predictor of ovarian response to stimulation protocols
[2]. We report a case that to our knowledge, is the first report
of live birth following donor oocytes used for IVF/ICSI from
an oocyte donor who herself was conceived via IVF.
Materials and methods
This case is reported after chart review of a successful out-
come. Patient-informed consent was not requested since all
patient data was de-identified. A computerized search was
performed in PubMed and Medline databases. The keywords
Capsule We report a case of live birth following donor oocyte in vitro
fertilization/intracytoplasmic sperm injection in which the oocyte donor
herself was conceived via IVF.
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and various combinations of phrases used in the search includ-
ed the following: BIVF offspring^, BIVF children^, Bfemale
fertility ,^ Bfemale infertility ,^ Bown fertility ,^ Bwomen born
from IVF ,^ Bconceive^, Bfertility ,^ Boocyte donor^, Begg
donor^, BART offspring^, and BART children^. None of the
encountered abstracts had reported the findings of this case
report.
Results
A 42 year-old nulligravid woman, with diminished ovarian
reserve, and her husband were interested in an IVF/ICSI cycle
with donor oocytes after having undergone an autologous
IVF/ICSI cycle with her own oocytes which resulted in a
negative serum hCG level without surplus embryos for cryo-
preservation. They selected a first-time screened and tested
23 year-old anonymous oocyte donor who was available
through an oocyte donation agency. The oocyte donor’s
AMH level was 4.2 ng/ml. Interestingly, her medical history
was significant for having been conceived via IVF. Her com-
ments reflected having being raised by her parents to have a
great appreciation for the IVF process and a desire to help
women who cannot have children to experience the joy of
doing so with assistance. She had previously delivered two
children of her own which she had conceived without
difficulty.
The oocyte donor’s ovarian stimulation protocol consisted
of an antagonist protocol with 300 IU of gonadotropins per
day. After 11 days of ovarian stimulation, the oocyte donor’s
peak estradiol level was 1369 pg/ml and her progesterone
level was 0.8 ng/ml. Recombinant hCG (Ovidrel) was admin-
istered subcutaneously for final oocyte maturation, and 27
oocytes were retrieved 35 h later. Nineteen oocytes were M2
oocytes. ICSI was performed for the 19 mature oocytes, of
which 11 fertilized and yielded 2PN zygotes and two yielded
3PN embryos; six mature oocytes did not fertilize. Ten of the
11 two pronuclear zygotes underwent cleavage and on day 3,
two embryos, each graded 8A in accordance with the SART
embryo grading system, were used for embryo transfer to the
recipient’s uterus. In addition, two day 6 surplus blastocysts,
each graded 3BB in accordance with the Gardner embryo
scoring system, were cryopreserved by means of vitrification.
The recipient unfortunately had a negative pregnancy test as a
result of her fresh embryo transfer.
The couple proceeded with frozen-thawed embryo transfer
4 months later. The wife’s endometrial preparation with an
estradiol and progesterone protocol resulted in a trilaminar
endometrium with a thickness of 9.0 mm. The two cryopre-
served blastocysts were thawed and transferred to the patient’s
uterus, resulting in pregnancy and live birth of a healthy sin-
gleton gestation.
Discussion
Since the initial years of IVF, many women who were conceived
via assisted reproductive technologies (ART) have reached re-
productive age and have had children of their own. Parallel to this
progression has been a significant increase in the utilization of
donor oocytes in recent years [3]. Success rates for donor oocyte
treatment cycles have been shown to be relatively stable for
recipients who are into their mid-forties and beyond [4, 5]. This
case report illustrates the case of an oocyte donor who was con-
ceived via IVF and had a good response to controlled ovarian
stimulation, a good number of oocytes retrieved, and the forma-
tion and cryopreservation of good quality supernumerary blasto-
cysts which, in a subsequent FET cycle, resulted in pregnancy
and live birth for a recipient couple. To our knowledge, this is the
first reported case of live birth following IVF/ICSI using oocytes
from an oocyte donor who was conceived via IVF herself. This
further supports the data that women born from IVF not only
have good fertility potential but also may meet criteria to be
oocyte donors as well.
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